InsiderTrades

Form 4 for BMY Bristol Myers Squibb

Accepted 2022-12-06 00:00:00 ET · period of report 2022-12-02 · accession 0000014272-22-000206 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-12-06 2022-12-02 BMY BOERNER CHRISTOPHER S. EVP, Chief Commercial Off F - Tax $81.13 -1,349 43.3K -3% -$109.4K
D 2022-12-06 2022-12-02 BMY BOERNER CHRISTOPHER S. EVP, Chief Commercial Off M - OptEx $0.00 +2,637 44.6K +6% $0
D 2022-12-06 2022-12-02 BMY BOERNER CHRISTOPHER S. EVP, Chief Commercial Off M - OptEx $0.00 -2,637 2,638 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, $0.10 par value 2022-12-02 F D 1,349 $81.13 43,254 D — — (F2) Shares withheld for payment of taxes upon vesting of awards.
2 Common Common Stock, $0.10 par value 2022-12-02 M A 2,637 $0.00 44,603 D — — (F1) The restricted stock unit vests in four equal annual installments beginning on December 2, 2020.
3 Derivative Restricted Stock Units 2022-12-02 M D 2,637 $0.00 2,638 D — · — to 2023-12-02 2,637 Common Stock, $0.10 par value (F3) Each restricted stock unit converts into one share of common stock upon vesting. (F1) The restricted stock unit vests in four equal annual installments beginning on December 2, 2020.